
Live Cell Encapsulation Market by Techniques (Coaxial Airflow, Electrostatic Dripping, Jet Cutting), Polymer (2-Hydroxyethyl Methacrylate & Methyl Methacrylate, Alginate, Cellulose Sulfate), Application - Global Forecast 2024-2030
Description
Live Cell Encapsulation Market by Techniques (Coaxial Airflow, Electrostatic Dripping, Jet Cutting), Polymer (2-Hydroxyethyl Methacrylate & Methyl Methacrylate, Alginate, Cellulose Sulfate), Application - Global Forecast 2024-2030
The Live Cell Encapsulation Market size was estimated at USD 312.29 million in 2023 and expected to reach USD 325.89 million in 2024, at a CAGR 4.44% to reach USD 423.54 million by 2030.
Global Live Cell Encapsulation Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Live Cell Encapsulation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Live Cell Encapsulation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Live Cell Encapsulation Market, highlighting leading vendors and their innovative profiles. These include Austrianova Singapore Pte Ltd, Beta-O2 Technologies Ltd., Biotime, Inc., Blacktrace Holdings Ltd., BÜCHI Labortechnik AG, Defymed SAS, Evonik Industries AG, Kadimastem, Living Cell Technologies Limited., Merck KGaA, Neurotech Holdings, LLC., Pharmacyte Biotech, Inc., Reed Pacific Pty Limited, Sernova Corporation, Sigilon Therapeutics, Inc., and Viacyte, Inc..
Market Segmentation & Coverage
This research report categorizes the Live Cell Encapsulation Market to forecast the revenues and analyze trends in each of the following sub-markets:
Techniques
Coaxial Airflow
Electrostatic Dripping
Jet Cutting
Liquid-Jet Break-Up
Rotating Disk Atomization
Simple Dripping
Vibrating-Jet Technique
Polymer
2-Hydroxyethyl Methacrylate & Methyl Methacrylate
Alginate
Cellulose Sulfate
Chitosan
PAN-PVC
Siliceous Encapsulates
Application
Cell Transplantation
Drug Delivery
Probiotics
Regenerative Medicine
Research
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Live Cell Encapsulation Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Live Cell Encapsulation Market?
3. What are the technology trends and regulatory frameworks in the Live Cell Encapsulation Market?
4. What is the market share of the leading vendors in the Live Cell Encapsulation Market?
5. Which modes and strategic moves are suitable for entering the Live Cell Encapsulation Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
191 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Live Cell Encapsulation Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing incidences of target diseases including target diseases, diphtheria, tetanus, poliomyelitis, measles, and tuberculosis
- 5.1.1.2. Investment via public-private investments to support the novel product development coupled with technology advancements
- 5.1.1.3. Public awareness related to the clinical role of encapsulated cells in disease management
- 5.1.2. Restraints
- 5.1.2.1. High production cost
- 5.1.3. Opportunities
- 5.1.3.1. Focus on Novel drug delivery systems
- 5.1.3.2. Ongoing research activities for development of live cell encapsulation
- 5.1.4. Challenges
- 5.1.4.1. Availability and adoption of alternative therapies
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Live Cell Encapsulation Market, by Techniques
- 6.1. Introduction
- 6.2. Coaxial Airflow
- 6.3. Electrostatic Dripping
- 6.4. Jet Cutting
- 6.5. Liquid-Jet Break-Up
- 6.6. Rotating Disk Atomization
- 6.7. Simple Dripping
- 6.8. Vibrating-Jet Technique
- 7. Live Cell Encapsulation Market, by Polymer
- 7.1. Introduction
- 7.2. 2-Hydroxyethyl Methacrylate & Methyl Methacrylate
- 7.3. Alginate
- 7.4. Cellulose Sulfate
- 7.5. Chitosan
- 7.6. PAN-PVC
- 7.7. Siliceous Encapsulates
- 8. Live Cell Encapsulation Market, by Application
- 8.1. Introduction
- 8.2. Cell Transplantation
- 8.3. Drug Delivery
- 8.4. Probiotics
- 8.5. Regenerative Medicine
- 8.6. Research
- 9. Americas Live Cell Encapsulation Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Live Cell Encapsulation Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.
- 10. South Korea
- 10.
- 11. Taiwan
- 10.
- 12. Thailand
- 10.
- 13. Vietnam
- 11. Europe, Middle East & Africa Live Cell Encapsulation Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.
- 10. Nigeria
- 11.
- 11. Norway
- 11.
- 12. Poland
- 11.
- 13. Qatar
- 11.
- 14. Russia
- 11.
- 15. Saudi Arabia
- 11.
- 16. South Africa
- 11.
- 17. Spain
- 11.
- 18. Sweden
- 11.
- 19. Switzerland
- 11.
- 20. Turkey
- 11.
- 21. United Arab Emirates
- 11.
- 22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Austrianova Singapore Pte Ltd
- 13.1.2. Beta-O2 Technologies Ltd.
- 13.1.3. Biotime, Inc.
- 13.1.4. Blacktrace Holdings Ltd.
- 13.1.5. BÜCHI Labortechnik AG
- 13.1.6. Defymed SAS
- 13.1.7. Evonik Industries AG
- 13.1.8. Kadimastem
- 13.1.9. Living Cell Technologies Limited.
- 13.1.
- 10. Merck KGaA
- 13.1.
- 11. Neurotech Holdings, LLC.
- 13.1.
- 12. Pharmacyte Biotech, Inc.
- 13.1.
- 13. Reed Pacific Pty Limited
- 13.1.
- 14. Sernova Corporation
- 13.1.
- 15. Sigilon Therapeutics, Inc.
- 13.1.
- 16. Viacyte, Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. LIVE CELL ENCAPSULATION MARKET RESEARCH PROCESS
- FIGURE 2. LIVE CELL ENCAPSULATION MARKET SIZE, 2023 VS 2030
- FIGURE 3. LIVE CELL ENCAPSULATION MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. LIVE CELL ENCAPSULATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. LIVE CELL ENCAPSULATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. LIVE CELL ENCAPSULATION MARKET DYNAMICS
- FIGURE 7. LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2023 VS 2030 (%)
- FIGURE 8. LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2023 VS 2030 (%)
- FIGURE 10. LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 12. LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. LIVE CELL ENCAPSULATION MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. LIVE CELL ENCAPSULATION MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.